This study is examining a new method, called selective plasma adsorption of extracellular DNA, to see if it can prevent the spread (metastasis) of pancreatic cancer during surgery. Extracellular DNA are bits of DNA that float outside of cells and can play a role in cancer spread. Researchers want to know if this method can improve survival and reduce the risk of cancer coming back.
Participants will have surgery to remove their pancreatic cancer. Some will receive the new treatment during and the day after surgery, while others will not. Everyone will have blood tests and CT scans before and after surgery to monitor their health.
- **Participation involves multiple visits**: blood tests and CT scans at set times up to a year after surgery.
- **Treatment and tests are free**: No cost for receiving the treatment, blood tests, or CT scans.
- **Risk of side effects**: As with any medical procedure, there may be risks to consider from plasma adsorption.